TEVA vs. INCR

Last updated Jul 30, 2026

TEVA (Teva Pharmaceutical Industries Limited) and INCR (INC Research Holdings Inc) are both stocks. Both operate in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Over the past 3 years, TEVA returned 59.46%/yr vs -18.00%/yr for INCR. Their 0.17 correlation means their historical movements had little consistent relationship.

Performance

TEVA vs. INCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Teva Pharmaceutical Industries Limited (TEVA) and INC Research Holdings Inc (INCR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, TEVA achieves a 11.21% return, which is significantly higher than INCR's -3.70% return.

TEVA

• 1D: 9.60%
• 1M: 4.20%
• 6M: 4.52%
• YTD: 11.21%
• 1Y: 109.85%
• 3Y*: 59.46%
• 5Y*: 29.18%
• 10Y*: -3.83%
• ALL TIME*: 12.22%

INCR

• 1D: -4.70%
• 1M: -15.60%
• 6M: -5.77%
• YTD: -3.70%
• 1Y: -40.95%
• 3Y*: -18.00%
• 5Y*: —
• 10Y*: —
• ALL TIME*: -34.72%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
INCR INC Research Holdings Inc	$14.61K	$21.73K	$47.96K
TEVA Teva Pharmaceutical Industries Limited	$188.09M	$178.04M	$201.57M

TEVA vs. INCR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
TEVA Teva Pharmaceutical Industries Limited	11.21%	41.61%	111.11%	14.47%	13.86%	-14.97%
INCR INC Research Holdings Inc	-3.70%	-42.77%	23.27%	-60.92%	-49.07%	-8.73%

Correlation

The correlation between TEVA and INCR is 0.02, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.02
Correlation (3Y) Balances recent behavior with more history.	0.09
Correlation (All Time) Calculated using the full available price history since Sep 1, 2021	0.17

The correlation between TEVA and INCR shifts across timeframes, from 0.02 (1 year) to 0.17 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap TEVA : $40.42B INCR : $50.08M
Total Revenue (TTM) TEVA : $17.31B INCR : ₪243.12M
Gross Profit (TTM) TEVA : $9.09B INCR : ₪40.61M
EBITDA (TTM) TEVA : $3.01B INCR : -₪79.49M

Return for Risk

TEVA vs. INCR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TEVA

TEVA Risk / Return Rank: 96
TEVA Sharpe Ratio Rank: 97
TEVA Sortino Ratio Rank: 97
TEVA Omega Ratio Rank: 96
TEVA Calmar Ratio Rank: 95
TEVA Martin Ratio Rank: 95

INCR

INCR Risk / Return Rank: 17
INCR Sharpe Ratio Rank: 14
INCR Sortino Ratio Rank: 15
INCR Omega Ratio Rank: 17
INCR Calmar Ratio Rank: 18
INCR Martin Ratio Rank: 21

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TEVA vs. INCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Teva Pharmaceutical Industries Limited (TEVA) and INC Research Holdings Inc (INCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	TEVA	INCR	Difference
Sharpe ratio: Return per unit of total volatility	2.70	-0.68	+3.38
Sortino ratio: Return per unit of downside risk	3.88	-0.87	+4.75
Omega ratio: Gain probability vs. loss probability	1.48	0.90	+0.58
Calmar ratio: Return relative to maximum drawdown	5.07	-0.71	+5.78
Martin ratio: Return relative to average drawdown	13.55	-1.07	+14.62

TEVA vs. INCR - Sharpe Ratio Comparison

The current TEVA Sharpe Ratio is 2.70, which is higher than the INCR Sharpe Ratio of -0.68. The chart below compares the historical Sharpe Ratios of TEVA and INCR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

TEVA vs. INCR - Drawdown Comparison

The maximum TEVA drawdown since its inception was -90.89%, roughly equal to the maximum INCR drawdown of -91.57%. Use the drawdown chart below to compare losses from any high point for TEVA and INCR.

Drawdown Indicators

	TEVA	INCR	Difference
Max Drawdown Largest peak-to-trough decline	-90.89%	-91.57%	+0.68%
Max Drawdown (1Y) Largest decline over 1 year	-21.79%	-57.80%	+36.01%
Max Drawdown (3Y) Largest decline over 3 years	-43.70%	-79.83%	+36.13%
Max Drawdown (5Y) Largest decline over 5 years	-43.70%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-88.41%	—	—
Current Drawdown Current decline from peak	-48.70%	-89.88%	+41.18%
Average Drawdown Average peak-to-trough decline	-32.07%	-66.04%	+33.97%
Ulcer Index Depth and duration of drawdowns from previous peaks	8.14%	38.49%	-30.35%

Volatility

TEVA vs. INCR - Volatility Comparison

The current volatility for Teva Pharmaceutical Industries Limited (TEVA) is 13.79%, while INC Research Holdings Inc (INCR) has a volatility of 16.93%. This indicates that TEVA experiences smaller price fluctuations and is considered to be less risky than INCR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TEVA	INCR	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.79%	16.93%	-3.14%
Volatility (6M) Calculated over the trailing 6-month period	27.42%	45.88%	-18.46%
Volatility (1Y) Calculated over the trailing 1-year period	40.98%	60.36%	-19.38%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	42.80%	65.23%	-22.43%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	47.55%	65.23%	-17.68%

Dividends

TEVA vs. INCR - Dividend Comparison

Neither TEVA nor INCR has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
INCR INC Research Holdings Inc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
TEVA Teva Pharmaceutical Industries Limited	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	3.88%	3.19%	1.77%

Financials

Frequently Asked Questions

Can I hold both TEVA and INCR in my portfolio?

TEVA and INCR have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, TEVA or INCR?

INCR has higher volatility (16.93%) compared to TEVA (13.79%). In terms of maximum drawdown, TEVA dropped -90.89% vs INCR's -91.57%.

Which has better risk-adjusted returns?

TEVA currently has the higher Sharpe Ratio (2.70 vs -0.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.